Skip to main content

Breast Cancer Research and Treatment

Ausgabe 1/2016

Inhalt (20 Artikel)

Review

Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations

Jeanne Murphy, Mark E. Sherman, Eva P. Browne, Ana I. Caballero, Elizabeth C. Punska, Ruth M. Pfeiffer, Hannah P. Yang, Maxwell Lee, Howard Yang, Gretchen L. Gierach, Kathleen F. Arcaro

Preclinical study

The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer

Cameron P. Capper, José M. Larios, Matthew J. Sikora, Michael D. Johnson, James M. Rae

Preclinical study

Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status

Jin You Kim, Hie Bum Suh, Hyun Jung Kang, Jong Ki Shin, Ki Seok Choo, Kyung Jin Nam, Seok Won Lee, Young Lae Jung, Young Tae Bae

Preclinical study

Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown

Su-Hyeong Kim, Eun-Ryeong Hahm, Julie A. Arlotti, Suman K. Samanta, Michelle B. Moura, Stephen H. Thorne, Yongli Shuai, Carolyn J. Anderson, Alexander G. White, Anna Lokshin, Joomin Lee, Shivendra V. Singh

Preclinical Study

Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer

Yukiko Tabuchi, Masafumi Shimoda, Naofumi Kagara, Yasuto Naoi, Tomonori Tanei, Atsushi Shimomura, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi

Open Access Preclinical study

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

Andrew R. Green, D. Soria, D. G. Powe, C. C. Nolan, M. Aleskandarany, M. A. Szász, A. M. Tőkés, G. R. Ball, J. M. Garibaldi, E. A. Rakha, J. Kulka, I. O. Ellis

Open Access Preclinical Study

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer

A. Thakkar, B. Wang, M. Picon-Ruiz, P. Buchwald, Tan A. Ince

Open Access Clinical trial

Prognostic impact of breast cancer subtypes in elderly patients

E. S. Bergen, C. Tichy, A. S. Berghoff, M. Rudas, P. Dubsky, Z. Bago-Horvath, R. M. Mader, R. Exner, M. Gnant, C. C. Zielinski, G. G. Steger, M. Preusser, R. Bartsch

Clinical Trial

Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14

Judith-Anne W. Chapman, Dennis C. Sgroi, Paul E. Goss, Elizabeth Zarella, Shemeica Binns, Yi Zhang, Catherine A. Schnabel, Mark G. Erlander, Kathleen I. Pritchard, Lei Han, Tanja Badovinac-Crnjevic, Lois E. Shepherd, Michael N. Pollak

Clinical trial

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Daniel Rayson, Sasha Lupichuk, Kylea Potvin, Susan Dent, Tamara Shenkier, Sukhbinder Dhesy-Thind, Susan L. Ellard, Catherine Prady, Muhammad Salim, Patricia Farmer, Ghasson Allo, Ming-Sound Tsao, Alison Allan, Olga Ludkovski, Maria Bonomi, Dongsheng Tu, Linda Hagerman, Rachel Goodwin, Elizabeth Eisenhauer, Penelope Bradbury

Epidemiology

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Kristen S. Purrington, Daniel W. Visscher, Chen Wang, Drakoulis Yannoukakos, Ute Hamann, Heli Nevanlinna, Angela Cox, Graham G. Giles, Jeanette E. Eckel-Passow, Sotiris Lakis, Vassiliki Kotoula, George Fountzilas, Maria Kabisch, Thomas Rüdiger, Päivi Heikkilä, Carl Blomqvist, Simon S. Cross, Melissa C. Southey, Janet E. Olson, Judy Gilbert, Sandra Deming-Halverson, Veli-Matti Kosma, Christine Clarke, Rodney Scott, J. Louise Jones, Wei Zheng, Arto Mannermaa, Diana M. Eccles, Celine M. Vachon, Fergus J. Couch

Epidemiology

Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)

Dawn L. Hershman, Lawrence H. Kushi, Grace Clarke Hillyer, Ellie Coromilas, Donna Buono, Lois Lamerato, Dana H. Bovbjerg, Jeanne S. Mandelblatt, Wei-Yann Tsai, Xiaobo Zhong, Judith S. Jacobson, Jason D. Wright, Alfred I. Neugut

Open Access Epidemiology

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Christopher M. Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin, Raluca Ionescu-Ittu, Marjolaine Gauthier-Loiselle, Roy Nitulescu, Nicholas Sicignano, Elizabeth Butts, Eric Q. Wu, Brian Barnett

Epidemiology

Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers

Shani Paluch-Shimon, Eitan Friedman, Raanan Berger, Moshe Papa, Maya Dadiani, Neil Friedman, Moshe Shabtai, Dov Zippel, Mordechai Gutman, Talia Golan, Ady Yosepovich, Raphael Catane, Tami Modiano, Bella Kaufman

Epidemiology

Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study

Avonne E. Connor, Kala Visvanathan, Kathy B. Baumgartner, Richard N. Baumgartner, Stephanie D. Boone, Lisa M. Hines, Roger K. Wolff, Esther M. John, Martha L. Slattery

Epidemiology

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study

Roberto Agresti, Elisabetta Meneghini, Paolo Baili, Pamela Minicozzi, Alberto Turco, Ilaria Cavallo, Francesco Funaro, Hade Amash, Franco Berrino, Elda Tagliabue, Milena Sant

Brief Report

Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis

P. Lavaud, B. Rousseau, Z. Ajgal, J. Arrondeau, O. Huillard, J. Alexandre, A. Hulin, F. Goldwasser

Brief Report

Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer

Tisha M. Felder, D. Phuong Do, Z. Kevin Lu, Lincy S. Lal, Sue P. Heiney, Charles L. Bennett

Letter to the Editor

Compliance with hormonal therapy

Henry J. Carson, Chirantan Ghosh

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.